Jun 27, 2025 04:42AM Citizens JMP Reiterates Market Outperform Rating on ProQR Therapeutics N.V. (PRQR)

Jun 26, 2025 04:30PM ProQR (PRQR) Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP

Apr 29, 2025 06:33AM Cantor Fitzgerald Starts ProQR Therapeutics N.V. (PRQR) at Overweight

Apr 28, 2025 04:01PM Evercore ISI Starts ProQR Therapeutics N.V. (PRQR) at Outperform, PT $5

Apr 23, 2025 04:24AM Citizens JMP Reiterates Market Outperform Rating on ProQR Therapeutics N.V. (PRQR)

Apr 14, 2025 07:02AM ProQR (PRQR) Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth

Mar 17, 2025 06:40AM ProQR Therapeutics N.V. (PRQR) PT Raised to $12 at H.C. Wainwright

Mar 14, 2025 12:23PM Raymond James Reiterates Strong Buy Rating on ProQR Therapeutics N.V. (PRQR)

Mar 10, 2025 02:54AM Citi Upgrades ProQR Therapeutics N.V. (PRQR) to Buy

Mar 7, 2025 04:30PM Citi Upgrades ProQR Therapeutics N.V. (PRQR) to Buy

Feb 11, 2025 04:06PM Jones Trading Starts ProQR Therapeutics N.V. (PRQR) at Buy, PT $11

Dec 12, 2024 06:45AM H.C. Wainwright Reiterates Buy Rating on ProQR Therapeutics N.V. (PRQR)

Dec 11, 2024 07:00AM ProQR (PRQR) Announces $8.1M in New Funding

Oct 22, 2024 04:01PM ProQR (PRQR) Announces Proposed Underwritten Public Offering of Ordinary Shares